Search
Ocular signs and symptoms
go.drugbank.com/conditions/DBCOND0173674Synonyms: Eye signs and symptoms, Ocular signs and symptomsOn and off phenomenon
go.drugbank.com/conditions/DBCOND0017875Drugs: AmantadineSynonyms: On and off phenomenonSodium and fluid retention
go.drugbank.com/conditions/DBCOND0099865Drugs: IndapamideSynonyms: Sodium and fluid retentionLevobupivacaine
go.drugbank.com/drugs/DB01002ApprovedInvestigationalWithdrawnto an anesthetic. … It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal
Products: COZELTI ICEREN 10ML X 10 AMPUL, COZELTI ICEREN 10ML X 10 AMPULEltrombopag
go.drugbank.com/drugs/DB06210ApprovedInvestigationalITP is a condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood. … Eltrombopag has also been recently approved (late 2012) for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based
Categories: Blood and Blood Forming OrgansProducts: Revolade Tablet 25mg, REVOLADE FILM-COATED TABLET 25MGErenumab
go.drugbank.com/drugs/DB14039ApprovedInvestigationalAimovig, as released and marketed by Novartis and Amgen, is in fact a novel therapeutic approach as the first and only FDA approved treatment specifically developed to prevent migraine by blocking the … Erenumab (AMG-334) (INN; trade name Aimovig) is a human monoclonal antibody designed specifically to bind and antagonize the calcitonin gene-related peptide receptor (CGRPR) as a means to prevent migraines
Categories: Amino Acids, Peptides, and ProteinsProducts: AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN 140MG/ML, AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/MLTerfenadine
go.drugbank.com/drugs/DB00342ApprovedInvestigationalWithdrawnIn the U.S., Terfenadine was superseded by fexofenadine in the 1990s due to the risk of cardiac arrhythmia caused by QT interval prolongation.
Categories: Histamine H1 Antagonists, Non-SedatingProducts: Seldane Tab 120mg, Apo-terfenadine Tab 120mgIsavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigationalIsavuconazonium is a second-generation triazole antifungal approved on March 6, 2015 by the FDA and July 2015 by the EMA for the treatment of adults with invasive aspergillosis and invasive mucormycosis … , marketed by Astellas under the brand Cresemba.
Categories: Isavuconazole and ProdrugsProducts: Cresemba 100mg Capsule, CRESEMBA CAPSULES 100MGTrovafloxacin
go.drugbank.com/drugs/DB00685ApprovedWithdrawnIt exerts its antibacterial activity by inhibiting the uncoiling of supercoiled DNA in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. … Trovafloxacin is a broad spectrum antibiotic that has been commonly marketed under the brand name Trovan by Pfizer.
Products: Trovan Tablets 100mgOcrelizumab
go.drugbank.com/drugs/DB11988ApprovedInvestigationalIt was later approved by Health Canada in August 2017, making the drug the first available treatment for PPMS in both the US and Canada. … [L1199] In phase 3 clinical trials of patients with PPMS, treatment with ocrelizumab led to lower clinical and MRI progression rates compared to placebo.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: OCREVUS 300mg/10mL Concentrate for Solution for Infusion, OCREVUS® CONCENTRADO PARA SOLUCION PARA INFUSION 300MG/10ML